| Factor Information | |
|---|---|
| Data ID | 1864 |
| Factor | age |
| Description | In our model using a combined outcome for stroke of either type, we found a significant interaction between CHD and age (neonatal versus childhood; P=0.03) |
| Biomarker | NA |
| Classification | E1 (physiological factor - age) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | CHD |
| p Value | 0.03 |
| Conclusion | The effect of CHD on stroke risk was different depending on whether the patient was a child or a neonate. CHD increased the point estimate of the OR for neonatal stroke, but the 95% CI included the null (OR, 1.5; 95% CI, 0.3–8.2). Among children >28 days, CHD increased the stroke risk 19-fold (OR, 19; 95% CI, 4.2–83. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 25516197 |
| Year | 2015 |
| Title | Community-based case-control study of childhood stroke risk associated with congenital heart disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | N/A | |
| Region | San Francisco & Oakland, USA | |
| Method | N/A | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | CHD surgery | |
| Group | neonatal(Treatment) | children(Control) |
| Number | 299 | 897 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | neonatal | children |
